GARDP seeks for a biotech industry expert in its board
GARD is looking for a new Board member with high-level executive experience and strategy setting in pharmaceutical/biotech industry. Applications and nominations will be accepted until 31 July.
The Global Antibiotic Research and Development Partnership (GARDP) Board is seeking to enhance its competencies with the addition of a Board member with high-level executive experience and strategy setting in pharmaceutical/biotech industry, including product research and development (R&D), manufacturing and commercialization.
GARDP is an independent, not-for-profit foundation registered under the Swiss Civil Code, administered by a Board of Directors (the Board). Board members are experts in their field and are chosen for their commitment to the public interest R&D, their technical competency, and their support of the mission of GARDP. The Board has powers over all matters pertaining to GARDP, notably, approving the overall policies and principles of GARDP, including those related to ethical considerations and fundraising strategies; approving project selection; and approving the annual work plan and budget.
Board members are selected from areas of expertise including (but not limited to) pharma/biotech research and development and related science, business development, clinical development, public health, fundraising, finance, legal, and global health communications and advocacy. The Board currently has six members.
The Board is seeking to enhance its competencies with the addition of a Board member with high-level experience in pharmaceutical R&D and/or product manufacturing. Board members serve a term of three years and serve in an honorary capacity. GARDP will reimburse reasonable expenses related to Board work, including travel expenses.
The closing date for applications is 31 July 2020. To nominate yourself or someone as a candidate, please download and complete the nomination form below and e-mail it to email@example.com.